Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: Matern Child Health J. 2016 Mar;20(3):542–549. doi: 10.1007/s10995-015-1852-5

Table 1.

Characteristics of mothers and infants according to final maternal treatment category, PEPI Study, Malawi, 2004-2009 (n=3,022)

HAART naïve CD4 <250 cells/mm3 HAART initiated HAART ineligible p-value

Baseline Maternal & Household Characteristics n=581 n=349 n=2092
Control arm, n (%) 188 (32.4) 98 (28.1) 683 (32.6) 0.24
Age, Mean yrs (SD) 27.2 (4.6) 28.3 (4.7) 25.7 (4.7) <0.01
Body Mass Index, Mean kg/m2 (SD) 23.6 (3.5) 23.6 (3.6) 23.9 (4.0) 0.05
CD4 count at enrollment, Median cells/mm3, (IQR) 211 (157-249) 174 (112-242) 485 (374-654) <0.01
Log10 viral load, Mean copies/ml (SD)a 4.3 (0.8) 4.4 (0.8) 3.9 (0.8) <0.01
Married, n (%) 538 (92.6) 314 (90.0) 1929 (92.2) 0.31
Parity, Median (IQR) 3 (2-4) 4 (3-5) 3 (2-4) <0.01
Education, n (%)
    No schooling 66 (11.4) 43 (12.3) 206 (9.8)
    Grade 1-8 289 (49.7) 175 (50.1) 1156 (55.3) 0.02
    Secondary or beyond 226 (38.9) 131 (37.6) 730 (34.9)
Electricity in the house, n (%) 192 (33.1) 117 (33.5) 682 (32.6) 0.93
Running water, n (%) 144 (24.8) 74 (21.2) 449 (21.5) 0.21

Endline Maternal Characteristics

Final CD4 count, Median cells/mm3, (IQR) 209 (154-252-) 270 (177-375) 493 (372-662) <0.01

Infant Characteristics

Combined infant treatment arm (NVP alone + NVP/ZDV), n (%) 393 (67.6) 251 (71.9) 1409 (67.4) 0.24
Birth weight, Mean grams (SD) 2993 (470) 2970 (450) 3052 (436) <0.01
Breastfeeding duration, Median days (IQR) 181 (98-188) 182 (180-185) 182 (165-270) <0.01

NVP = Nevirapine; ZDV = Zidovudine; SD = Standard deviation; IQR = Interquartile range. Differences in means, medians and proportions were compared using analysis of variance (ANOVA), Wilcoxon rank-sum tests and chi-squared statistics respectively.

a

Viral load n=2726